The Quantellect read.As of Nov 19, 2026, 3 active firms cover Stereotaxis Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.02 next quarter toward $-0.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
—
Average target across 0 active firms as of Nov 19, 2026 vs $0.94 current
Highest Target—
Average Target—
Lowest Target—
STXS analyst recommendation trends
86420
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Strong BuyBuyNeutralSellStrong Sell
RATING
JUN
JUL
AUG
SEP
OCT
NOV
Strong Buy
0
0
0
0
0
0
Buy
3
3
4
4
4
3
Neutral
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
3
3
4
4
4
3
As of Nov 19, 2026, 3 of 3 active firms rate STXS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
STXS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.02
Range $-0.02 – $-0.02 · 1 analysts
Next period, 1 analysts expect Stereotaxis Inc to earn $-0.02 a share (range $-0.02 – $-0.02), versus — a year earlier. Full-year consensus is $-0.23, growing to $-0.17 the year after.
REVENUE · NEXT QUARTER
$9.5M
Range $9.5M – $9.5M · 1 analysts
Revenue is expected to reach $9.5M (range $9.5M – $9.5M). Full-year consensus is $31.6M, rising to $40.2M next year.
Top analysts covering Stereotaxis Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on STXS.
#1
KB
Kyle Bauser
Roth Capital
Buy
$4.00+327.6% to target
Coverage
—
+ Follow
#2
DS
Daniel Stauder
JMP Securities
Buy
$4.00+327.6% to target
Coverage
—
+ Follow
STXS stock forecast FAQ
Is STXS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover STXS?+
3 active firms have a recognized rating on Stereotaxis Inc as of Nov 19, 2026.
Who is the most accurate analyst covering STXS?+
Among analysts who currently cover STXS, Kyle Bauser of Roth Capital has the strongest overall Quantellect track record. Their current call is Buy with a $4.00 target.
What is Stereotaxis Inc's projected EPS for next quarter?+
The consensus estimate is $-0.02 per share (range $-0.02 – $-0.02) across 1 analysts. Full-year EPS is projected at $-0.23, rising to $-0.17 the following year.
How much revenue is Stereotaxis Inc expected to report next quarter?+
Consensus revenue is $9.5M (range $9.5M – $9.5M). Full-year revenue is projected at $31.6M, growing to $40.2M next year.
Have analysts been upgrading or downgrading STXS lately?+
As of Nov 19, 2026, 3 of 3 active firms rate STXS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their STXS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.